Copper prevents amyloid-β1–42 from forming amyloid fibrils under near-physiological conditions in vitro
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
The aggregation and deposition of amyloid-β((1-42) )(Aβ(42)) in the brain is implicated in the aetiology of Alzheimer's disease (AD). While the mechanism underlying its deposition in vivo is unknown its precipitation in vitro is influenced by metal ions. For example, Aβ(42) is known to bind copper, Cu(II), in vitro and binding results in aggregation of the peptide. The biophysical properties of Cu(II)-Aβ(42) aggregates are of significant importance to their putative involvement in the amyloid cascade hypothesis of AD and are currently the subject of strong debate. In particular the question has been raised if sub- and super-stoichiometric concentrations of Cu(II) act in opposing ways in respectively accelerating and preventing amyloid fibril formation by Aβ(42). Herein we have used fluorimetry and transmission electron microscopy to provide unequivocal evidence that under near-physiological conditions both sub- and super-stoichiometric concentrations of Cu(II) prevented the assembly of Aβ(42) into ThT-positive β-sheet rich amyloid fibrils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In plaques from persons with Alzheimer’s disease, iron and aluminum appear to cause plaque formation while copper and zinc may be protective [26,27,28,35,36,37].”
From The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline (2017) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In inhibition experiments, a reduced ThT fluorescence was observed for the Cu2+- and Zn2+-containing fibrils, as reported previously (Figure 6).21,49,50”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several studies showed that Zn2+ promotes formation of nonfibrillar aggregates,16,29–31 yet conflicting results have been reported for the Cu2+-mediated Aβ aggregation.21,28,32,33”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Viles, J. H. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.05.003 · Cited by 404
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294
Self-citationThe role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266
Schrag, M., Mueller, C., Oyoyo, U., Smith, M. A., & Kirsch, W. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.001 · Cited by 263
New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., & Takashima, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010706200 · Cited by 244
Ha, C., Ryu, J., & Park, C. B. (2007) · Biochemistry · doi:10.1021/bi7000032 · Cited by 231
Regulation of solute and water balance and cell volume in the central nervous system.
Strange, K. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v3112 · Cited by 231
Copper signaling in the mammalian nervous system: Synaptic effects
Gaier, E. D., Eipper, B. A., & Mains, R. E. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23143 · Cited by 209
Cited by
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497
Natural product-based amyloid inhibitors
Velander, P., Wu, L., Henderson, F., Zhang, S., Bevan, D. R., & Xu, B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.004 · Cited by 202
“While there are still debates about the inhibitory or accelerating effects these metals may have on amyloid formation in vitro [87,89,90], it is”
BackgroundAlzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 150
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
Ejaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 143
“While, the dietary copper addition leads to an increase of intracellular copper concentration in APP/PS1 AD mice [160], which has been shown in parenchymal Aβ plaques, a decrease of AD pathology, but no loss of neurons seen [152,153].”
BackgroundThe effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity
Sharma, A. K., Pavlova, S. T., Kim, J., Kim, J., & Mirica, L. M. (2013) · Metallomics · doi:10.1039/c3mt00161j · Cited by 150
Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
Abelein, A., Gräslund, A., & Danielsson, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421961112 · Cited by 122
“Miller Y, Ma B, Nussinov R (2010) Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.”
BackgroundMethodInfluentialRana, M., & Sharma, A. K. (2018) · Metallomics · doi:10.1039/c8mt00203g · Cited by 119
Science and art of protein formulation development
Wang, W., & Ohtake, S. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118505 · Cited by 116
Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
Phan, H. T. T., Samarat, K., Takamura, Y., Oussou-Azo, A. F., Nakazono, Y., & Vestergaard, M. C. M. (2019) · Nutrients · doi:10.3390/nu11040756 · Cited by 112
“We also measured the aggregation extent of Aβ_42 incubated with Cu2+ ions, reported to inhibit Aβ fibrillation [38,39], as a positive control.”
Biophysical Studies of the Amyloid β‐Peptide: Interactions with Metal Ions and Small Molecules
Wärmländer, S. K. T. S., Tiiman, A., Abelein, A., Luo, J., Jarvet, J., Söderberg, K. L., Danielsson, J., & Gräslund, A. (2013) · ChemBioChem · doi:10.1002/cbic.201300262 · Cited by 110
Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Jones, M. R., Mathieu, E., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Wee Yong, V., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 96
Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation
Stewart, K. L., & Radford, S. E. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0271-9 · Cited by 102
“Copper ion binding occurs more readily at mildly acidic pH resulting in characteristic insoluble plaques, while at physiological pH, soluble Aβ40 and Aβ42 aggregates have been observed (Atwood et al. 1998; Mold et al. 2013).”
BackgroundGomes, L. M., Vieira, R. P., Jones, M. R., Wang, M. C. P., Dyrager, C., de Souza-Fagundes, E. M., Silva, J. G. D., Storr, T., & Beraldo, H. D. O. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.011 · Cited by 101
Fe2+binding on amyloid β-peptide promotes aggregation
Boopathi, S., & Kolandaivel, P. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25075 · Cited by 75
“…of Zn21-Ab and Cu21Ab have been investigated in detail by NMR,7–9 X-ray absorption spectroscopy10,11 and Fourier transform infrared spectroscopy.12 Mold et al.13 have used fluo- rimetry and transmission electron microscopy to pro- vide evidence that under which physiological conditions sub- and…”
MethodZhou, Z., Chen, S., Huang, Y., Gu, B., Li, J., Wu, C., Yin, P., Zhang, Y., & Li, H. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113858 · Cited by 74
ATP7B Variants as Modulators of Copper Dyshomeostasis in Alzheimer’s Disease
Squitti, R., Polimanti, R. A., Siotto, M., Bucossi, S., Ventriglia, M., Mariani, S., Vernieri, F., Scrascia, F., Trotta, L., & Rossini, P. M. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8237-y · Cited by 73
Graham, S. F., Nasaruddin, M. L., Carey, M. P., Hölscher, C., McGuinness, B., Kehoe, P. G., Love, S., Passmore, P., Elliott, C. T., Meharg, A. A., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140684 · Cited by 65
“Recently it has controversially been reported that copper may reduce the formation of beta-sheets in plaques [20] and therefore could be considered ‘protective’, and so the loss of copper is in fact a detrimental consequence giving rise to increased levels of betasheet formation.”
BackgroundMatheou, C. J., Younan, N. D., & Viles, J. H. (2015) · Biochemical Journal · doi:10.1042/bj20141168 · Cited by 64
Niu, W., & Guo, J. (2013) · Molecular BioSystems · doi:10.1039/c3mb70204a · Cited by 64
Liu, Z., Deng, Q., Qin, G., Yang, J., Zhang, H., Ren, J., & Qu, X. (2023) · Chem · doi:10.1016/j.chempr.2023.06.003 · Cited by 60
Singh, R. S., Mishra, N. K., Kumar, V., Vinayak, V., & Joshi, K. B. (2018) · ChemBioChem · doi:10.1002/cbic.201800220 · Cited by 53
Pickart, L., Vasquez-Soltero, J., & Margolina, A. (2017) · Brain Sciences · doi:10.3390/brainsci7020020 · Cited by 51
Current understanding of metal-dependent amyloid-β aggregation and toxicity
Yi, Y., & Lim, M. H. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00208f · Cited by 53
Zhang, Q., Hu, X., Wang, W., & Yuan, Z. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01603 · Cited by 50
Effects of Cu(II) on the aggregation of amyloid-β
Weibull, M. G. M., Simonsen, S., Oksbjerg, C. R., Tiwari, M. K., & Hemmingsen, L. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01727-5 · Cited by 54
Cu II Binding to Various Forms of Amyloid‐β Peptides: Are They Friends or Foes?
Borghesani, V., Aliès, B., & Hureau, C. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201700776 · Cited by 59
Sharma, A. K., Kim, J., Prior, J. T., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2014) · Inorganic Chemistry · doi:10.1021/ic500926c · Cited by 53
Nam, G., Hong, M., Lee, J., Lee, H. J., Ji, Y., Kang, J., Baik, M., & Lim, M. H. (2020) · Chemical Science · doi:10.1039/d0sc02046j · Cited by 51
Shardlow, E., Mold, M. J., & Exley, C. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00048 · Cited by 45
Self-citationMonette, A., & Mouland, A. J. (2020) · Viruses · doi:10.3390/v12101179 · Cited by 48
“Most intriguingly, compared to other metals, Cu2+ binding to Aβ is more kinetically favored, and Cu2+ can bind to previously self-aggregated Aβ [18].”
BackgroundChaves, S., Resta, S., Rinaldo, F., Costa, M., Josselin, R., Gwizdała, K., Piemontese, L., Capriati, V., Pereira-Santos, A. R., Cardoso, S. M., et al. (2020) · Molecules · doi:10.3390/molecules25040985 · Cited by 43
CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease
Crivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00780-0 · Cited by 46
“All samples for TEM were prepared via a modi ed TEM staining protocol (37).”
MethodSelf-citationRedox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro
Sasanian, N., Bernson, D., Horváth, I., Wittung-Stafshede, P. E., & Esbjörner, E. K. (2020) · Biomolecules · doi:10.3390/biom10060924 · Cited by 42
“Whilst a few studies report that Cu2+ ions induce the formation of amorphous aggregates of Aβ(1-42) [48,90], the TEM analysis revealed the formation of mature amyloid fibrils at both sub- and super-stoichiometric Cu2+ concentrations (Figure 2c,d) in our case.”
BackgroundCopper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity
Gámez, P., & Caballero, A. B. (2015) · AIP Advances · doi:10.1063/1.4921314 · Cited by 38
Jones, M. R., Dyrager, C., Hoarau, M., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., & Storr, T. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.022 · Cited by 35
Dharmadana, D., Reynolds, N. P., Conn, C. E., & Valéry, C. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0160 · Cited by 33
Histidine‐Rich Oligopeptides To Lessen Copper‐Mediated Amyloid‐β Toxicity
Caballero, A. B., Terol‐Ordaz, L., Espargaró, A., Vázquez, G., Nicolás, E., Sabaté, R., & Gamez, P. (2016) · Chemistry – A European Journal · doi:10.1002/chem.201600286 · Cited by 31
Versatile nanomaterials for Alzheimer’s disease: Pathogenesis inspired disease-modifying therapy
Xi, Y., Chen, Y., Jin, Y., Han, G., Song, M., Song, T., Shi, Y., Tao, L., Huang, Z., Zhou, J., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.034 · Cited by 27
Small angle X-ray scattering analysis of Cu2+-induced oligomers of the Alzheimer's amyloid β peptide
Ryan, T. M., Kirby, N. M., Mertens, H. D. T., Roberts, B. R., Barnham, K. J., Cappai, R., Pham, C. L. L., Masters, C. L., & Curtain, C. C. (2015) · Metallomics · doi:10.1039/c4mt00323c · Cited by 31
Copper, dityrosine cross-links and amyloid-β aggregation
Vázquez, G., Caballero, A. B., Kokinda, J., Hijano, A., Sabaté, R., & Gámez, P. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01734-6 · Cited by 27
Khan, H. Y., Ahmad, A., Hassan, M. N., Khan, Y. H., Arjmand, F., & Khan, R. H. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215580 · Cited by 32
Cisternas, P., Zolezzi, J. M., Lindsay, C. B., Rivera, D. S., Martinez, A. N., Bozinovic, F., & Inestrosa, N. C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180729 · Cited by 29
Molecular dynamics simulation of aluminium binding to amyloid-β and its effect on peptide structure
Turner, M., Mutter, S. T., Kennedy-Britten, O. D., & Platts, J. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217992 · Cited by 28
Stefaniak, E., Atrián‐Blasco, E., Goch, W., Sabater, L., Hureau, C., & Bal, W. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202004484 · Cited by 33
Probing oligomerization of amyloid beta peptide in silico
Dorosh, L., & Stepanova, M. (2016) · Molecular BioSystems · doi:10.1039/c6mb00441e · Cited by 28
Dey, C., Roy, M., Pal, P., Ghosh, R., & Dey, S. G. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00544b · Cited by 24
Evidence of two oxidation states of copper during aggregation of hen egg white lysozyme (HEWL)
Ghosh, S., PANDEY, N. K., Bhattacharya, S., Roy, A., May, N. V., & Dasgupta, S. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.02.014 · Cited by 21
Ciaglia, T., Miranda, M. R., Micco, S. D., Vietri, M., Smaldone, G., Musella, S., Sarno, V. D., Auriemma, G., Sardo, C., Moltedo, O., et al. (2024) · Antioxidants · doi:10.3390/antiox13121585 · Cited by 22
Somavarapu, A. K., Shen, F., Teilum, K., Zhang, J., Mossin, S., Thulstrup, P. W., Bjerrum, M. J., Tiwari, M. K., Szunyogh, D., Søtofte, P. M., et al. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201703440 · Cited by 20
Effect of ferric citrate on amyloid‐beta peptides behavior
Galante, D., Cavallo, E., Perico, A., & D’Arrigo, C. (2018) · Biopolymers · doi:10.1002/bip.23224 · Cited by 21
Coupling of Zinc-Binding and Secondary Structure in Nonfibrillar Aβ40 Peptide Oligomerization
Xu, L., Shan, S., Chen, Y., Wang, X., Nussinov, R., & Ma, B. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00063 · Cited by 18
Singh, A., Datta, P., & Pandey, L. M. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.01.045 · Cited by 18
Azmi, N. H., Ismail, M., Ismail, N., Imam, M. U., Alitheen, N. B., & Abdullah, M. A. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/153684 · Cited by 26
Intertwined Pathologies of Amyloid-β and Metal Ions in Alzheimer’s Disease: Metal–Amyloid-β
Nam, G., & Lim, M.-H. (2019) · Chemistry Letters · doi:10.1246/cl.190281 · Cited by 12
Few-layer bismuth selenides exfoliated by hemin inhibit amyloid-β1–42 fibril formation
Peng, J., Xiong, Y., Lin, Z., Sun, L., & Weng, J. (2015) · Scientific Reports · doi:10.1038/srep10171 · Cited by 15
Murariu, M., Habasescu, L., Ciobanu, C. I., Grădinaru, V. R., Pui, A., Drochioiu, G., & Mangalagiu, I. I. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-018-9738-1 · Cited by 16
A Preliminary Study of Cu Exposure Effects upon Alzheimer’s Amyloid Pathology
Pilozzi, A. R., Yu, Z., Carreras, I., Cormier, K., Hartley, D. M., Rogers, J. T., Dedeoglu, A., & Huang, X. (2020) · Biomolecules · doi:10.3390/biom10030408 · Cited by 14
Reciprocal modulation of Aβ42 aggregation by copper and homocysteine
Keskitalo, S., Farkas, M., Hanenberg, M., Szodorai, A., Kulic, L., Semmler, A., Weller, M., Nitsch, R. M., & Linnebank, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00237 · Cited by 14
“A recent study of Mold et al. (2013) addresses this dilemma by fluorimetry and transmission electron microscopy (TEM).”
BackgroundInfluence of Zeolites on Amyloid-β Aggregation
Lucas, M. J., & Keitz, B. K. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b01496 · Cited by 14
Copper ions trigger disassembly of neurokinin B functional amyloid and inhibit de novo assembly
Jayawardena, B. M., Jones, M. R., Hong, Y., & Jones, C. E. (2019) · Journal of Structural Biology · doi:10.1016/j.jsb.2019.09.011 · Cited by 12
Pedrero-Prieto, C. M., Frontiñán-Rubio, J., Alcain, F. J., Durán‐Prado, M., Peinado, J. R., & Rabanal‐Ruiz, Y. (2021) · Diagnostics · doi:10.3390/diagnostics11091655 · Cited by 14
Duroux, C., & Hagège, A. (2021) · Metallomics · doi:10.1093/mtomcs/mfab075 · Cited by 11
Modulation of beta-amyloid aggregation using ascorbic acid
Sampaio, I., Quatroni, F. D., Lins, P. M. P., Nascimento, A. S., & Zucolotto, V. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.006 · Cited by 11
Molecular dynamics simulations of copper binding to amyloid-β Glu22 mutants
Mutter, S. T., Turner, M., Deeth, R. J., & Platts, J. A. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e03071 · Cited by 10
Kalaiarasi, G., Mohankumar, A., Dharani, S., Dallemer, F., Sundararaj, P., & Prabhakaran, R. (2021) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202100039 · Cited by 11
Further insight into the role of metals in amyloid formation by IAPP1-37 and ProIAPP1-48
Mold, M. J., Bunrat, C., Goswami, P., Roberts, A. N., Roberts, C. F., Taylor, N., Taylor, H. K., Wu, L., Fraser, P. E., & Exley, C. (2015) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-4-4 · Cited by 8
“However, ‘lag’ phases in amyloid formation are rarely observed under-near physiological conditions [4,15] and what we observed were increases in the rate of formation of β sheets of amyloid which also occurred, if to a lesser extent, following sham seeding.”
BackgroundSelf-citationRevisiting Cu(II) Bound Amyloid-β40 and Amyloid-β42 Peptides: Varying Coordination Chemistries
Coskuner‐Weber, O. (2018) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.424144 · Cited by 8
“Namely, the αhelical abundance of residues Glu22-Gly25 is increased in the Cu:His3Tyr10-Aβ(1-42) alloform as to Cu:His3Tyr10-Aβ(1-40).”
BackgroundKumar, R., Pavlov, P. F., & Winblad, B. G. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190695 · Cited by 9
Luo, J., Wang, H., Wu, J., Romankov, V., Daffé, N., & Dreiser, J. G. (2021) · iScience · doi:10.1016/j.isci.2021.103465 · Cited by 7
“The spectrum of the 1000 mM sample (incubated for 1 day at 30 C) has a slightly lower intensity of the p* peak and a different pre-peak feature that could originate from the structural changes because of the different aggregation pathway in the presence of the concentrated Cu(II) ions (Han et al., 2021; Mold et al., 2…”
BackgroundIntracellular tracing of amyloid vaccines through direct fluorescent labelling
Mold, M. J., Kumar, M., Mirza, A., Shardlow, E., & Exley, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-20845-9 · Cited by 7
Self-citationMannem, R., Yousuf, M., & Sreerama, L. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00684 · Cited by 7
“The mesh of fibers in peptide P3 incubated with HNQ disappeared (Figure 1B) as has been observed in similar studies on inhibitor action of 1,4-naphthoquinones (Gill, 2014), quinones (Gong et al., 2014), and other polyphenols (Ono et al., 2003), and copper (Mold et al., 2013) on amyloid formations.”
ResultShardlow, E., Khan, B., & Exley, C. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126766 · Cited by 8
Self-citationZhang, R., Ai, H., Zhu, X., & Li, Q. (2016) · ChemPhysChem · doi:10.1002/cphc.201600004 · Cited by 7
Grasso, G., Komatsu, H., & Axelsen, P. H. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.06.007 · Cited by 8
Shardlow, E., & Exley, C. (2019) · RSC Advances · doi:10.1039/c9ra03831k · Cited by 8
Self-citationBall, S. R., Adamson, J. S. P., Sullivan, M. A., Zimmermann, M. R., Lo, V., Sanz-Hernández, M., Jiang, X., Kwan, A. H., McKenzie, A. D. J., Werry, E. L., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00498 · Cited by 6
Roldán-Martín, L., Sodupe, M., & Maréchal, J. (2024) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c04555 · Cited by 7
The co-effect of copper and lipid vesicles on Aβ aggregation
Zhu, X., Liu, W., Zhao, W., Chang, Z., & Yang, J. (2022) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2022.184082 · Cited by 5
Anti-fibrillogenic and fibril destabilizing effects of metal ions on cystatin fibrils
Bhat, W. F., Bhat, S. A., Bhat, I. A., Sohail, A., Shah, A., & Bano, B. (2017) · Process Biochemistry · doi:10.1016/j.procbio.2017.03.021 · Cited by 5
Hen lysozyme fibrillogenesis, molten globule intermediate and effect of copper salts
Cerón, R., Peimbert, M., Rojo‐Domínguez, A., & Nájera, H. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2006090 · Cited by 5
“On the other hand, the presence of Cu(II) ions inhibits the aggregation of the Ab1-42 peptide (Mold et al., 2013).”
BackgroundModulating Role of TTR in Aβ Toxicity, from Health to Disease
Cardoso, I., Santos, L. M., & Alemi, M. (2016) · InTech eBooks · doi:10.5772/63194 · Cited by 8
“More recently, and also in the presence of some contradictory results [84], copper was found to bind strongly to Aβ aggregates, inhibiting in vitro amyloid fibril formation [85].”
Essential Role of Histidine for Rapid Copper(II)-Mediated Disassembly of Neurokinin B Amyloid
Jayawardena, B. M., Peacey, L., Gamsjaeger, R., & Jones, C. E. (2022) · Biomolecules · doi:10.3390/biom12111585 · Cited by 3
“Copper has previously been shown to not influence ThT excitation or emission [22,28,29].”
BackgroundStability differences in the NMR ensembles of amyloid β fibrils
Alred, E. J., Phillips, M., Bhavaraju, M., & Hansmann, U. H. E. (2016) · Journal of Theoretical and Computational Chemistry · doi:10.1142/s0219633616500590 · Cited by 3
Paulo, S. L., Ribeiro‐Rodrigues, L., Rodrigues, R. S., Mateus, J. M., Fonseca‐Gomes, J., Soares, R., Diógenes, M. J., Solá, S., Sebastião, A. M., Ribeiro, F. F., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201567 · Cited by 2
In vitro screening on amyloid beta modulation of aqueous extracts from plant seeds
Okada, Y., & Okada, M. (2015) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.171688 · Cited by 2
Sayyah, E., Kurul, E., Tunç, H., & Durdağı, S. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00201 · Cited by 1
Binding of Cu2+ to Aβ1-29 causes aggregation and toxicity in SH-SY5Y cells
Taniguchi, M., Saito, M., Kuga, T., & Yamagishi, N. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.031 · Cited by 2
Peptide backbone-copper ring structure: A molecular insight into copper-induced amyloid toxicity
Wang, J., Jiang, X., Su, X., Zhou, X., Wang, Y. T., Wang, G., Geng, H., Jiang, Z. R., Fang, H., Chen, G., et al. (2022) · Chinese Physics B · doi:10.1088/1674-1056/ac8920 · Cited by 1
New Research Suggests Copper Is Linked with Alzheimer's Disease
Valeo, T. (2013) · Neurology Today · doi:10.1097/01.nt.0000435578.11462.67
Optical Detection of Interaction between Alzheimer's Disease Biomarkers and Carbon Nanotubes
Zaheer, A. (2014) · TSpace (University of Toronto)
Responsive Peptide-based Materials: Stimulation by Chemical and Biological Signals
Khalily, M. P., Ramakers, B. E. I., Guo, H., & Löwik, D. W. P. M. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166136-00343
NMR probing of copper–amyloid β1–16 interactions and self-assembly
Sunanda, P., Raghothama, S., Palempalli, U. M. D., & Krishnarjuna, B. (2024) · Academia Biology · doi:10.20935/acadbiol7451 · Cited by 1
Choi, J., Jeong, H., Ramalingam, M., Hwang, J., Kim, B. C., Kim, B. C., Jeong, H., & Jang, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-08015-0
Isotopic Dilution Provides No Evidence for Cu2+-Bridged β-Amyloid Homo-Oligomers
Drew, S. C. (2025) · Applied Magnetic Resonance · doi:10.1007/s00723-025-01795-8
Chiang, C.-I., Liu, C., Hao, P.-J., Chu, C., Chu, C.-Y., Liu, C., Hu, C., Lee, Y.-L. A., Hu, C., Liu, Y., et al. (2025) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2025.106507
Crivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14053548
Self-citationCrivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14053545
Self-citationCrivelli, S. M., Luo, Q., Stevens, J., Giovagnoni, C., van Kruining, D., Bode, G. H., den Hoedt, S., Hobo, B., Scheithauer, A.-L., Walter, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14053551
Self-citationValence-sensitive assembly of a Cu–amyloid peptide network
Sementilli, A., Kim, Y., Li, W., Stewart, K. L., Yue, J., Warncke, K., & Lynn, D. (2026) · Chemical Communications · doi:10.1039/d6cc03903k
Metadata
- Authors
- Mold, M., Ouro-Gnao, L., Wieckowski, B. M., & Exley, C.
- Affiliations
- Keele University (GB)
- Corresponding author
- Exley, Christopher
- Venue
- Scientific Reports
- Published
- 2013-02-13
- Volume
- 3
- Issue
- 1
- Pages
- 1256-1256
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3570782
- OpenAlex
- W2012108930
- Cited by
- 101
- References
- 35
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 2 · 2022: 8 · 2021: 12 · 2020: 10 · 2019: 10 · 2018: 8 · 2017: 12 · 2016: 9 · 2015: 9 · 2014: 7 · 2013: 5
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Engineering and Physical Sciences Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Keywords
- amyloid-beta 42, copper(II), amyloid fibril formation, Alzheimer's disease, metal ion binding, peptide aggregation, ThT fluorescence, beta-sheet, amyloid hypothesis
- MeSH terms
- Amyloid, Copper, Edetic Acid, Ions, Microscopy, Fluorescence, Peptide Fragments, Protein Binding, Amyloid beta-Peptides, Microscopy, Electron, Transmission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.